CD8+ T Cells Cause Disability and Axon Loss in a Mouse Model of Multiple Sclerosis

Collateral Bystander Damage by Myelin-Directed CD8+ T Cells Causes Axonal Loss

(2009) Bettina Sobottka et al.   AMERICAN JOURNAL OF PATHOLOGY

Pathogenic CD8+T cells in multiple sclerosis

(2009) Manuel A. Friese et al.   ANNALS OF NEUROLOGY

The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease?

(2009) Howard L. Weiner   ANNALS OF NEUROLOGY

Functional characterization of mouse spinal cord infiltrating CD8+ lymphocytes

(2009) Chandra Deb et al.   JOURNAL OF NEUROIMMUNOLOGY

Demyelinated Axons and Motor Function Are Protected by Genetic Deletion of Perforin in a Mouse Model of Multiple Sclerosis

(2009) Chandra Deb et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study

(2009) Eva Havrdova et al.   LANCET NEUROLOGY

Unanticipated demyelinating pathology of the CNS

(2009) Darin T. Okuda   Nature Reviews Neurology

Progressive Multifocal Leukoencephalopathy after Natalizumab Monotherapy

(2009) Hans Lindå et al.   NEW ENGLAND JOURNAL OF MEDICINE

Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF

(2008) C MALMESTROM et al.   JOURNAL OF NEUROIMMUNOLOGY

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis

(2008)   NEW ENGLAND JOURNAL OF MEDICINE